EP Patent

EP0482576A1 — Prolonged release dosage form of drug and method for producing the same

Assigned to Freund Corp · Expires 1992-04-29 · 34y expired

What this patent protects

A prolonged release dosage form of drug made by coating a surface of an ungranulated main medicinal particle with a water-insoluble material which is physiologically acceptable and does not dissolve in water and gastric juice; and then, granulating or tableting the coated medicin…

USPTO Abstract

A prolonged release dosage form of drug made by coating a surface of an ungranulated main medicinal particle with a water-insoluble material which is physiologically acceptable and does not dissolve in water and gastric juice; and then, granulating or tableting the coated medicinal particles thus-obtained.

Drugs covered by this patent

Patent Metadata

Patent number
EP0482576A1
Jurisdiction
EP
Classification
—
Expires
1992-04-29
Drug substance claim
No
Drug product claim
No
Assignee
Freund Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.